Primary breast lymphoma: A single-institute experience in Taiwan

Primary breast lymphoma: A single-institute experience in Taiwan

Background: Breast is an uncommon location of lymphoma involvement. The most common type of primary breast lymphoma (PBL) is diffuse large B-cell lymphoma (DLBCL). Rituximab is the widely used monoclonal antibody against CD20+ B-cell lymphoma, especially DLBCL. We aimed to analyze the clinical featu...

Full description

Bibliographic Details
Main Authors: Che-Wei Ou, Lee-Yung Shih, Po-Nan Wang, Hung Chang, Ming-Chung Kuo, Tzung-Chih Tang, Jin-Hou Wu, Tung-Liang Lin, Yu-Shin Hung, Po Dunn
Format: Article
Language:English
Published: Elsevier 2014-10-01
Series:Biomedical Journal
Subjects:
diffuse large B-cell lymphoma
primary breast lymphoma
rituximab
Online Access:http://www.biomedj.org/article.asp?issn=2319-4170;year=2014;volume=37;issue=5;spage=321;epage=325;aulast=Ou

Internet

http://www.biomedj.org/article.asp?issn=2319-4170;year=2014;volume=37;issue=5;spage=321;epage=325;aulast=Ou

Similar Items